Seeing Is Believing
CTKB is currently covered by 4 analysts with an average price target of $7.31. This is a potential upside of $3.11 (74.05%) from yesterday's end of day stock price of $4.2.
Cytek Biosciences's activity chart (see below) currently has 54 price targets and 34 ratings on display. The stock rating distribution of CTKB is 28.57% SELL, 57.14% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 36.22% with an average time for these price targets to be met of 31.6 days.
Highest price target for CTKB is $7.5, Lowest price target is $3, average price target is $5.38.
Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 11-Nov-2025. First documented stock forecast 17-Aug-2021.
Currently out of the existing stock ratings of CTKB, 2 are a SELL (28.57%), 4 are a BUY (57.14%), 1 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2022
$7.5
$3.26 (76.89%)
$8
3 months 7 days ago
(11-Nov-2025)
3/15 (20%)
$2.71 (56.58%)
29
Hold Since 13-May-2022
$7
$2.76 (65.09%)
$9
8 months 21 days ago
(28-May-2025)
6/9 (66.67%)
$4.51 (181.12%)
28
Buy Since 19-Mar-2025
$4
$-0.24 (-5.66%)
$6
9 months 2 days ago
(16-May-2025)
1/2 (50%)
$1.33 (49.81%)
83
Sell Since 03-Feb-2025
$3
$-1.24 (-29.25%)
$4.5
9 months 6 days ago
(12-May-2025)
4/9 (44.44%)
$-0.02 (-0.66%)
18
Buy Since 17-Aug-2021
$12
$7.76 (183.02%)
$17
2 years 3 months 10 days ago
(08-Nov-2023)
0/2 (0%)
$7 (140.00%)
What is CTKB (Cytek Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on CTKB (Cytek Biosciences) with a proven track record?
Which analyst has the current lower performing score on CTKB (Cytek Biosciences) with a proven track record?
Which analyst has the most public recommendations on CTKB (Cytek Biosciences)?
Which analyst is the currently most bullish on CTKB (Cytek Biosciences)?
Which analyst is the currently most reserved on CTKB (Cytek Biosciences)?